I

Inventionmed SA
WSE:INM

Watchlist Manager
Inventionmed SA
WSE:INM
Watchlist
Price: 0.106 PLN 2.42% Market Closed
Market Cap: 21.5m PLN

Intrinsic Value

The intrinsic value of one INM stock under the Base Case scenario is 0.182 PLN. Compared to the current market price of 0.106 PLN, Inventionmed SA is Undervalued by 42%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

INM Intrinsic Value
0.182 PLN
Undervaluation 42%
Intrinsic Value
Price
I
Worst Case
Base Case
Best Case

Valuation History
Inventionmed SA

What is Valuation History?
Ask AI Assistant
What other research platforms think about INM?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is INM valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Inventionmed SA.

Explain Valuation
Compare INM to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Contacts
Loading...
How do you feel about INM?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Inventionmed SA

Current Assets 1.3m
Cash & Short-Term Investments 50k
Receivables 756.1k
Other Current Assets 475.6k
Non-Current Assets 37m
Long-Term Investments 9.1m
PP&E 27.7m
Intangibles 73.3k
Current Liabilities 14.4m
Accounts Payable 245.8k
Accrued Liabilities 14.1m
Other Current Liabilities 1.2k
Non-Current Liabilities 23.5m
Other Non-Current Liabilities 23.5m
Efficiency

Free Cash Flow Analysis
Inventionmed SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Inventionmed SA

Revenue
2.3m PLN
Cost of Revenue
-244.8k PLN
Gross Profit
2m PLN
Operating Expenses
-3m PLN
Operating Income
-992.4k PLN
Other Expenses
-1.5m PLN
Net Income
-2.5m PLN
Fundamental Scores

INM Profitability Score
Profitability Due Diligence

Inventionmed SA's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

27/100
Profitability
Score

Inventionmed SA's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

INM Solvency Score
Solvency Due Diligence

Inventionmed SA's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
41/100
Solvency
Score

Inventionmed SA's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

INM Price Targets Summary
Inventionmed SA

There are no price targets for INM.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Inventionmed SA
does not pay dividends
Shareholder Yield

Current shareholder yield for INM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one INM stock?

The intrinsic value of one INM stock under the Base Case scenario is 0.182 PLN.

Is INM stock undervalued or overvalued?

Compared to the current market price of 0.106 PLN, Inventionmed SA is Undervalued by 42%.

Back to Top